- ►diabetesjournals.org J Rosenstock, P Hollander, S Chevalier, A … - Diabetes care, 2008 - Am Diabetes Assoc RESULTS—A total of 281 patients were randomly assigned; 278 were exposed to
treatment, and 236 (84.9%) completed the study. Baseline A1C (7.9%) was reduced
by −0.8% with rimonabant versus −0.3% with placebo (Δ A1C −0.51%; P ... Cited by 16 - Related articles - All 3 versions
- ►oxfordjournals.org LF Van Gaal, AJ Scheen, AM Rissanen, S … - European Heart Journal, 2008 - Eur Soc Cardiology Methods and results: Patients with a body mass index 30 or >27 kg/m 2 with
treated/untreated hypertension, dyslipidaemia, or both, were randomized to
double-blind treatment with placebo, rimonabant 5 or 20 mg once daily plus ... Cited by 27 - Related articles - All 9 versions
- ►diabetesjournals.org [PDF] J Rosenstock, P Hollander, S Chevalier, A … - Diabetes Care, 2008 - Am Diabetes Assoc Julio Rosenstock MD1, Priscilla Hollander MD2, Soazig Chevalier MS3, Ali
Iranmanesh MD4; for the SERENADE study group. ... 1Dallas Diabetes and
Endocrine Center, TX, USA; 2Baylor Endocrine Center, TX, USA; 3sanofi- ... Cited by 3 - Related articles - All 3 versions
J Rosenstock, P Hollander, S Chevalier, A … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—A total of 281 patients were randomly assigned; 278 were exposed to
treatment, and 236 (84.9%) completed the study. Baseline A1C (7.9%) was reduced
by −0.8% with rimonabant versus −0.3% with placebo (Δ A1C −0.51%; P ... Related articles - All 5 versions
- ►nursing2008.com JP Despres, R Ross, G Boka, N Almeras, I … - Arteriosclerosis, thrombosis, and vascular biology, 2008 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Effect of Rimonabant on the High- ... Cited by 8 - Related articles - All 6 versions
M Rajesh, P Mukhopadhyay, G Haskó, P … - Biochemical and Biophysical Research …, 2008 - Elsevier Vascular smooth muscle proliferation and migration triggered by inflammatory
stimuli and chemoattractants such as platelet-derived growth factor (PDGF) are
key events in the development and progression of atherosclerosis and ... Cited by 7 - Related articles - All 2 versions
D Jones - Nature reviews. Drug discovery, 2008 - ncbi.nlm.nih.gov 1: Nat Rev Drug Discov. 2008 Dec;7(12):961-2. End of the line for cannabinoid
receptor 1 as an anti-obesity target? Jones D. A wave ... Cited by 17 - Related articles - All 2 versions
- ►nursing2008.com SE Nissen, SJ Nicholls, K Wolski, J Rodes- … - Jama, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 95 - Related articles - BL Direct - All 5 versions
P Pacher, P Mukhopadhyay, R Mohanraj, G … - Hypertension, 2008 - Am Heart Assoc Endocannabinoids, endogenous lipid mediators generated by virtually all cell
types both in the brain and peripheral tissues, elicit a broad range of
biological effects similar to those of marijuana. The endocannabinoid ... Cited by 12 - Related articles - All 6 versions
AJ Scheen - Journal of neuroendocrinology, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 12 - Related articles - BL Direct - All 4 versions
